In agreement with this, administration of the ATX inhibitor, GLPG1690, at the time of irradiation with five fractions of 7.5 Gy to breast tumors in mice decreased proliferation of breast cancer cells in the remaining tumor following the irradiation [126]. Here, ENPP2 is linked to breast carcinoma.